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AbstrAct
Background Inflammatory bowel disease (IBD) 
predominantly affects young adults at critical 
socioeconomic periods of their lives. There are 
no studies examining the process of transfer 
of care for adult patients with IBD changing 
healthcare providers. Our aims were to assess 
the quality of referral information provided 
when patients with an established IBD diagnosis 
transfer care between heathcare providers 
and to assess the impact of referral quality on 
patient outcome.
Methods Retrospective data pertaining to IBD 
transfer of care referrals were collected from 16 
hospitals across London over a 2- month period. 
Data were collected on patient demographics, 
source and content of referral and cross- 
referenced with an established transfer of care 
checklist. Patient outcome within the 6 months 
following transfer was also documented.
Results 154 cases were identified, over half 
of which transferred due to patient relocation. 
Details included in transfer letters were in many 
cases incomplete. In over 70% of cases, the 
letter came from primary care, including when a 
tertiary opinion was sought. Although referrals 
from primary care contained fewer patient data 
points, there was no association with poor 
patient outcomes at 6 months.
Conclusion This is the first study examining 
the quality of transfer of care in adult patients 
with IBD. We highlighted a significant and 
underreported issue and found that the majority 
of referrals were led by primary care. Though 
the inclusion in the referral of fewer data points 
was not associated with poor outcomes, we 
highlighted an area where gastroenterologists 
might take more responsibility to provide smooth 
and robust transfer of care.
IntroductIon
The prevalence of inflammatory bowel 
disease (IBD) is increasing, affecting 1 in 
125 people in the UK,1 the majority of 
patients cared for in a hospital setting. 
Incidence peaks in the third and fourth 
decades of life, affecting people at critical 
social and economic periods of their lives. 
This population is particularly mobile 
and likely to move to locations more 
frequently than older persons2; hence, 
there is the potential for frequent changes 
in healthcare providers, which may impact 
on care.
Significance of this study
What is already known on this topic
 ► Patients with inflammatory bowel disease 
(IBD) undergoing paediatric to adult 
transition benefit from the application of 
quality standards to minimise disruption 
to their continuity of care.
What this study adds
 ► We demonstrate the previously unknown 
scale of IBD patient transfer in the greater 
London region and show that this process 
is largely led by general practitioners 
rather than gastroenterologists.
How might it impact on clinical 
practice in the foreseeable future
 ► We believe this study will inform the 
development of new standards of care for 
patients with established IBD who wish to 
transfer their care between providers.
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A multidisciplinary approach is currently the gold 
standard in providing holistic care with most patients 
requiring regular outpatient follow- up and long- term 
medication to prevent disease flares and associated 
complications.3 Continuity of care is vital in managing 
IBD, and we can learn from studies of the process of 
transition from paediatric to adult care. Although this 
is also a relatively under- researched area, there are 
comprehensive guidelines and pathways for the tran-
sitioning of care between paediatric and adult IBD 
services.4 Crucially, difficulties in transition for this 
cohort have been shown to negatively impact engage-
ment with health services and adherence to therapy.5
There is a paucity of evidence regarding adult 
patients with IBD who need to transfer their care to a 
new secondary or tertiary care provider, both in terms 
of how effectively this is done and whether it affects 
outcome. There is a risk of miscommunication when 
patients move between care providers, and currently, 
there is no metric capturing this process.6 We do not 
know how common transfer of care in adult patients 
with IBD is, nor how it may impact on their experience 
and disease course.
This is the first study, to our knowledge, to look 
into this under- researched area of IBD care. We expect 
our findings to inform future guidelines as well as the 
expected standards of IBD care, with the aim of bene-
fiting patients and their carers.
AIms
Our primary aim was to assess the quality of referral 
for adult patients transferring care between providers, 
according to the number of key data points included 
in the referral. This was assessed against the Corner-
stones Health ‘IBD Checklist for Care Continuity’ (see 
online supplementary appendix).
Our secondary aims were to identify the frequency 
of transfer of care among the London population and 
to report disease- related outcomes in patients transfer-
ring their care, determining whether the quality of the 
referral was related to poor outcome.
methods
The pan- London Gastroenterology London Investiga-
tive Network for Trainees network is a collaborative 
group of trainees based at hospitals across London. 
Participation in the trainee network is on a volun-
tary basis, and individuals self- selected to collect data 
from individual hospital sites according to an agreed 
proforma. Retrospective data were obtained for outpa-
tient IBD transfer of care referrals between 1 January 
and 28 February 2018.
We identified all referrals for new adult patients 
attending outpatient clinics who were transferring 
their care from an existing gastroenterology team 
elsewhere. All new patients with IBD attending outpa-
tients were included in the study, and all patients had 
an established diagnosis of IBD.
Since no prescriptive standards currently exist in 
the UK or continental Europe on optimal clinical 
documentation in regard to transfer of care in IBD, 
we elected to use as a guide the IBD Checklist for 
Care Continuity provided by Cornerstones Health, 
a US- based not- for- profit organisation aiming to 
advance IBD care worldwide. To our knowledge, this 
is the only widely available document with guidance 
on continuity of care for patients with IBD, though it 
has not previously been used as a research tool.6 This 
is a freely available checklist based on the consensus of 
international IBD experts and was used as a guide for 
the data collection.
Original notes, electronic data and clinic letters were 
interrogated. Local departmental approval was gained 
each for each participating site.
Variables collected
Adults over the age of 18 years were included if they 
had an existing diagnosis of IBD and were transfer-
ring to a secondary or tertiary healthcare provider. 
Hospital records were assessed for measures of good 
quality care transition as derived from Cornerstones 
Health IBD Checklist for Care Continuity.6
The following information was recorded on a stan-
dardised proforma: patient demographics, source of 
transfer letter and reason for transfer, information 
relating to the IBD diagnosis (type of IBD, Montreal 
classification, medication history, surgical history, 
coexisting conditions, latest endoscopy and imaging) 
and patient outcome within 6 months of a consultation 
following the referral. This study aimed to identify 
missing data; therefore, data points not recorded in the 
transfer of care dataset were treated as not recorded. 
Where there were missing data in the outcome data, 
that is, no data on steroid use, those data were reported 
as missing and were excluded from the analysis. A 
poor outcome was defined as experiencing at least one 
of the following: a clinically diagnosed disease flare, 
steroid prescription, Accident and Emergency (A&E) 
attendance or hospitalisation.
Analysis
Discrete variables were analysed by Fisher’s exact test. 
Continuous variables were analysed by Kruskall- Wallis 
test with correction for multiple comparisons using 
the Benjamini, Krieger and Yekutieli correction (false 
discovery rate (FDR) 0.05). Statistics was performed 
using GraphPad Prism V.7 (TreeStar).
results
Population
In total, 16 centres were included in the study. A total 
of 154 referrals of patients with known IBD diagnoses 
were identified in the 2- month study period. Fourteen 
referrals were excluded from analysis either as a result 
of incomplete referral data (n=6) or as they concerned 
transition from paediatric to adult care (n=8). A total 
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Figure 1 (A) Pie chart showing the reason given for transfer across 
all patients in the cohort. (B) Box plot showing the ages of patients 
grouped by their reason for transfer. (C) Box plot showing the ages 
of patients grouped by their geographical origin of transfer (London 
denotes transfer within London; UK denotes transfer from another 
location within the UK; International denotes transfer from outside the 
UK). Statistics was obtained using Kruskall- Wallis test with correction 
for multiple comparisons (FDR 0.05). Only statistically significant 
differences are displayed on the graphs.
Figure 2 (A) Pie chart showing the sources of the referral letter. (B) 
Pie charts showing sources of the referral letter grouped by the reason 
for transfer (i–iv as indicated).
of 140 referrals to transfer care received in 14 centres 
were therefore included in the analysis. Diagnoses were 
ulcerative colitis in 53.5% (n=75), Crohn's disease in 
45.7% (n=64) and IBD unclassified in 0.7% (n=1).
reason for transfer of care
The majority of transfers of adult care were for those 
moving geographical area (n=74, 52.9%), followed by 
those seeking a transfer into the NHS from the private 
sector (n=23, 16.4%), those seeking second opin-
ions (n=21, 15%), those being referred for a tertiary 
opinion (n=14, 10%) or those lost to follow- up (n=3, 
2.1%) (figure 1A). In five cases (3.6%), the reason for 
referral was unclear in the referral letter.
The median age of referred patients was 32 years 
(IQR 26–46). The median age of patients seeking a 
second opinion was 51 years (IQR 34.5–65.5), which 
was significantly greater than those transferring their 
care due to a geographical relocation (27 years; IQR 
24–38, q<0.001) (figure 1B). There were no statisti-
cally significant differences in age at referral between 
groups of patients transferring their care for other 
reasons.
The geographical origin of referrals was examined 
where data were available (n=91). Patients transfer-
ring care within London were significantly older at 33 
years (IQR 27.0–50.75, n=48) compared with those 
transferring their care into London from other parts 
of the UK (26 years; IQR 22–31, n=23, q=0.003) 
(figure 1C). There was no significant difference 
between those referred within or into London from 
the UK and those immigrating from outside (28.5 
years; IQR 24.25–44.5, n=20).
source of referral information
To assess which group of practitioners is responsible 
for transfer of data, the primary referral source was 
assessed in each case. In the majority of cases, infor-
mation regarding transfer of care came from primary 
care (n=100, 71.4%), with a minority coming from 
secondary care (n=29, 20.7%), and the rest, exclu-
sively in the setting of those transferring from the 
private sector, came from private practice (n=11, 
7.9%) (figure 2A).
The majority of referrals for those moving area were 
performed by primary care as opposed to secondary 
care (62 of 74 cases, 83.8%). This was also reflected 
in those being referred for a second opinion, in which 
primary care clinicians performed the majority of 
referrals (16 of 21 cases, 76.2%). Over half of transfers 
from private practice were also performed by primary 
care (12 of 23 cases, 52.2%) (figure 2Biii), and half 
of all referrals for a tertiary opinion were made by 
primary care (7 of 14 cases, 50%) (figure 2Biv). Any 
patients who were lost to follow- up were re- referred 
by primary care (n=3). There were five referrals for 
which the reason for transfer was not evident in the 
referral letter.
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Figure 3 (A) Bar chart showing the proportion of letters which 
included each of eight data points identified as required, grouped by 
referral source. (date denotes the date of diagnosis; Montreal denotes 
sufficient information to establish Montreal classification; current med 
denotes current medication; last endoscopy denotes the last endoscopy 
report; last imaging denotes the last imaging report; comorbidities). 
Analysed by Fisher’s exact test. *P<0.05. Only statistically significant 
differences are displayed on the graphs. (B) Box plot showing the total 
number of data points included in each referral grouped by referral 
source. Hx, history; Med Hx, medication Hx. Surg Hx, surgical history.
Figure 4 Bar chart showing the percentage of patients experiencing 
adverse outcome grouped according to whether each required data 
point was included or not included, and whether four or more data 
points were included or not included. There were no statistically 
significant differences found.
Information included in referral
The Cornerstone transfer of care bundle aims to 
improve the quality of transfer through the inclusion 
of specific details of care of patients with IBD.5 The 
inclusion of key pieces of data was assessed according 
to referral source, as demonstrated in figure 3A. 
Several criteria were documented more frequently 
by secondary care referrers compared with primary 
care referrers. These included the date of diagnosis 
(96.6% vs 64%, p=0.0003), medical history (89.7% 
vs 27%, p<0.0001), surgical history (65.5% vs 
23%, p<0.0001), the most recent endoscopy report 
(51.7% vs 21%, p=0.002) and the most recent imaging 
findings (48.3% vs 11%,p<0.0001). However other 
data points, including data sufficient to apply the 
Montreal classification (28% vs 13%, not significant 
(n.s.)), current medication (90% vs 87%, n.s.) and 
comorbidities (52% vs 39%, n.s.) were equally likely 
to be included regardless of the referral source.
Overall referral letters contained a median of three 
(IQR 2–4) data points per letter. The median number 
of data points was significantly higher in referrals from 
secondary care (n=4, IQR 4–5) compared with those 
from primary care (n=2, IQR 2–3, q<0.0001) and 
private practice (n=3, IQR 2–5, q=0.01) (figure 3B). 
Hence, while primary care performs the majority of 
such referrals, the data supplied from secondary care 
are in most cases significantly more complete than 
those from primary care.
outcomes in the 6 months after a consultation following 
referral
Patient records were assessed for evidence of adverse 
outcomes in the 6 months after initial outpatient clin-
ical review. A poor outcome was defined as having 
any one of a clinically diagnosed disease flare, steroid 
prescription, emergency department attendance or 
hospitalisation.
Overall, 36 (26%) patients experienced at least 
one adverse event, meeting the definition of a ‘poor 
outcome’. Twenty- seven patients (19%) were diag-
nosed with a disease flare; 20 (14%) required a steroid 
prescription; 11 (8%) had a documented attendance to 
an emergency care department; and 9 (6%) required 
hospital admission.
When the reason for transfer of care was analysed 
by outcome, a poor outcome was demonstrated in 
5 patients (36%) referred for a tertiary opinion, 23 
(31%) referred due to moving area, 4 (17%) referred 
from the private sector, 2 (10%) referred due to the 
patient seeking a second opinion and 2 (40%) with 
unknown reason for transfer. There was no signifi-
cant difference in the proportions experiencing a poor 
outcome between each of these groups (p=0.193).
Each of the eight data points of interest in the referral 
letter was analysed by outcome (figure 4). No statis-
tical difference was found in the proportion of patients 
experiencing a good outcome when comparing those 
in whom each data point was included versus not 
included. There was also no statistical difference in the 
proportion of patients experiencing a good outcome 
when comparing those in whom the referral letter had 
included four or more data points with those in whom 
less than four had been included.
dIscussIon
This is the first study to our knowledge exploring 
the transfer of care for adult patients with an estab-
lished diagnosis of IBD within providers in the UK. 
Using a large network of London- based gastroenter-
ology trainees, we were able to collect data from both 
secondary and tertiary hospitals serving a culturally 
diverse population. We found that relocation was the 
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predominant reason for change of healthcare provider. 
Interestingly, most referrals were facilitated by primary 
care despite previous follow- up by another secondary 
care provider, and these referrals appeared to lack key 
clinical information. Escalation of therapy and other 
metrics of disease complications were identified in a 
quarter of the referred patients regardless of aetiology 
of provider change.
There were a large number of patients transferring 
their care into hospitals in the Greater London region 
during the 2- month period of our study. On an annual 
basis, there are likely to be almost 1000 patients trans-
ferring their care into or between these London hospi-
tals. These were predominantly young adults who 
may be moving to study or to take up new employ-
ment in the capital. Although it is not clear whether 
these figures can be extrapolated nationally, it appears 
that the young IBD population is mobile. Secondary 
care providers may not always be aware of a patient’s 
intentions to move providers, which would limit their 
ability to provide a smooth transition to the receiving 
team. We believe it is therefore essential to empower 
patients to take ownership of their continuity of their 
care, and the emerging use of ‘app’ technology and 
data centralisation may have a role in this.
Most of the literature relating to transfers of IBD 
care describes the transition of adolescent patients 
from paediatric to adult services. Transfers of care in 
this context are also associated with increased health 
services use, with increased outpatient and emergency 
department visits.7 There are less data on the impact 
of adult patients moving between services, although 
recent studies in the UK and the USA have shown that 
fragmentation of IBD care—the use of more than one 
secondary care service—is common. In a retrospec-
tive study of administrative data in the UK, 17% of 
adult patients with IBD accessed a second outpatient 
IBD service within 2 years of their diagnosis.8 Younger 
patients and those living in metropolitan areas had 
higher rates of this care fragmentation.8 The use of 
multiple inpatient IBD services is also common. In 
another administrative dataset, from the USA, up 
to 33% of inpatients with IBD were readmitted to a 
different IBD service within 90 days.9 Again, younger 
patients were more susceptible to this care fragmenta-
tion, which was associated with worsening lengths of 
stay and in- hospital mortality.9
We found that, regardless of the reason for care 
transfer, the responsibility for the majority of referrals 
largely fell to primary care. Compared with direct refer-
rals from gastroenterologists, referrals from primary 
care were less comprehensive. Lack of education on 
the essential clinical information for IBD- related conti-
nuity of care may be one of the contributing factors 
explaining this observation, but it is also possible that 
access to results of imaging and endoscopy in primary 
care is limited by insufficient communication. Barriers 
to clinical data access across healthcare providers in 
the UK remain a problem.10 Digital health technologies 
allowing for personal clinical information control may 
be one of the potential answers to this problem and 
would also allow for patient autonomy and smoother 
care transfer.10 11
Care transfers and care fragmentation for adult 
patients in IBD have been an under- researched field. 
Currently, there is no validated evidence to define 
continuity of care as a process measure of importance 
in IBD.12 The non- profit organisation Cornerstones 
Health sought to address this with an expert- informed 
checklist, documenting important elements of the IBD 
disease phenotype and treatment history.6 The check-
list has not previously been used as a research tool to 
grade quality of care. Future work should evaluate the 
metrics that best categorise continuity of care in IBD 
and whether a supported implementation of the check-
list improves those process outcomes.
Aiming to reduce variation in data collection, we 
implemented a strict data collection and data curation 
protocol as described in methodology. However, we 
were unable to access primary care records directly, 
basing our findings on hospital records in secondary 
and tertiary care. As a result, we were not able to 
fully describe the clinical characteristics of the popu-
lation and to identify factors associated with poor 
outcomes relating to disease activity. Furthermore, 
other outcomes that were not investigated include 
patient satisfaction and increased cost and discomfort 
from repeat investigations. This study aimed to investi-
gate the primary communication between referrer and 
receiving team; attempts by the receiving team to retro-
spectively obtain the information were not captured. 
However, this represents extra time and work for the 
receiving team, something that may be avoided by 
improving initial referrals. Further limitations include 
the fact that in some UK hospitals, referral straight 
from the private sector is not allowed, placing the onus 
back on to primary care, where access to all informa-
tion may not be available.
conclusIon
In conclusion, our study highlights the previously 
underappreciated frequency of transfer of care between 
care providers for adult patients with an established 
diagnosis of IBD. In all settings, primary care appears 
to be the main facilitator of care transfer, but the lack 
of inclusion of significant metrics of care suggests 
they are less well equipped to manage this process. 
We believe that good communication between the 
patient, gastroenterologists and primary care is essen-
tial to facilitate smooth transfer of care, and that the 
use of digital health technologies may enable patients 
to take individual ownership of the transfer process. 
Wherever possible, we believe that gastroenterologists 
working in secondary care and in the private sector 
should take a proactive role in ensuring high- quality 
referral to the patient’s receiving team.
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